64.54
0.45%
0.29
After Hours:
64.54
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $64.54, with a volume of 1.38M.
It is up +0.45% in the last 24 hours and down -0.66% over the past month.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$64.25
Open:
$64.57
24h Volume:
1.38M
Relative Volume:
0.54
Market Cap:
$26.95B
Revenue:
$4.80B
Net Income/Loss:
$-66.50M
P/E Ratio:
6,454.00
EPS:
0.01
Net Cash Flow:
$558.47M
1W Performance:
+0.67%
1M Performance:
-0.66%
6M Performance:
+35.87%
1Y Performance:
+42.50%
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
353 N. CLARK STREET, CHICAGO, IL
Compare VTR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
VTR
Ventas Inc
|
64.54 | 26.95B | 4.80B | -66.50M | 558.47M | 0.01 |
WELL
Welltower Inc
|
139.30 | 87.22B | 7.35B | 915.62M | 2.01B | 0.48 |
DOC
Healthpeak Properties Inc
|
22.24 | 15.81B | 2.53B | 309.54M | 953.27M | 0.19 |
OHI
Omega Healthcare Investors Inc
|
40.67 | 10.97B | 1.01B | 347.99M | 685.44M | 0.96 |
HR
Healthcare Realty Trust Inc
|
18.48 | 6.65B | 1.29B | -588.17M | 230.02M | -0.7256 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-30-24 | Initiated | Deutsche Bank | Buy |
Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
Oct-03-23 | Initiated | Wedbush | Neutral |
Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Apr-20-23 | Initiated | Wells Fargo | Overweight |
Nov-01-22 | Reiterated | Credit Suisse | Outperform |
Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
Jun-23-22 | Initiated | Credit Suisse | Outperform |
Jun-03-22 | Initiated | CapitalOne | Overweight |
May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
Feb-01-22 | Initiated | Credit Suisse | Neutral |
Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
Jul-14-21 | Resumed | Mizuho | Neutral |
Jun-15-21 | Initiated | Wolfe Research | Outperform |
Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
Jan-06-21 | Initiated | Robert W. Baird | Neutral |
Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
Sep-08-20 | Downgrade | Argus | Buy → Hold |
Sep-02-20 | Resumed | Stifel | Hold |
Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
Dec-20-19 | Resumed | Mizuho | Neutral |
Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
Nov-19-19 | Upgrade | Argus | Hold → Buy |
Oct-30-19 | Downgrade | Stifel | Buy → Hold |
Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas announces pricing of senior notes offering - MSN
Fmr LLC Grows Stock Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
(VTR) Trading Signals - Stock Traders Daily
Quantbot Technologies LP Makes New $6.60 Million Investment in Ventas, Inc. (NYSE:VTR) - MarketBeat
Harvest Fund Management Co. Ltd Grows Stake in Ventas, Inc. (NYSE:VTR) - MarketBeat
Thrivent Financial for Lutherans Has $3.75 Million Stock Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
REITs: Key Demographic Trends Driving Opportunity - Seeking Alpha
Ventas's SWOT analysis: healthcare REIT stock poised for growth amid challenges - Investing.com
Ventas, Inc. (NYSE:VTR) Shares Sold by Vision Capital Corp - MarketBeat
Ventas, Inc. (NYSE:VTR) Shares Purchased by Daiwa Securities Group Inc. - MarketBeat
Ventas, Inc. (NYSE:VTR) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
Charles Schwab Investment Management Inc. Raises Stock Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New Investment in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas Inc. stock underperforms Friday when compared to competitors - MarketWatch
VTRVentas, Inc. Latest Stock News & Market Updates - StockTitan
Here's Why Ventas Stock is an Apt Portfolio Pick for Now - MSN
Ventas, Inc. (NYSE:VTR) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat
Natixis Advisors LLC Grows Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas Adds to Jax Sr. Housing Portfolio - Connect CRE
Ventas Inc. stock rises Thursday, still underperforms market - MarketWatch
Ventas Earns Nareit 2024 Healthcare “Leader in the Light” Award - sharewise
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Wins Double Nareit Awards for Industry-Leading Sustainability & Net Zero Strategy | VTR Stock News - StockTitan
Is Wall Street Bullish or Bearish on Ventas Stock? - MSN
Swiss National Bank Purchases 9,800 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
CEO Debra Cafaro Leads The Way at Health Care REIT Ventas - Nareit
Seniors housing outlook boosts Ventas stock prospects despite NIH budget concerns. - Investing.com
Ventas, Inc. (NYSE:VTR) Shares Bought by Impax Asset Management Group plc - MarketBeat
How to Take Advantage of moves in (VTR) - Stock Traders Daily
Ventas prices offering of 10.6M shares of common stock - MSN
Ventas Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Ventas to Present at REITworld 2024: Healthcare REIT Giant Showcases Portfolio Strategy | VTR Stock News - StockTitan
What's in the Offing for Ventas Stock This Earnings Season? - MSN
ING Groep NV Trims Stock Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
KBC Group NV Has $36.56 Million Stock Position in Ventas, Inc. (NYSE:VTR) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 112,020 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
Ventas announces underwritten offering of 10.6M shares of common stock - MSN
Ventas Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Ventas prices $677 million stock offering By Investing.com - Investing.com Canada
Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock - sharewise
Ventas prices $677 million stock offering - Investing.com
Ventas announces public offering of 10.6 million shares - REITsWeek
Ventas announces 10.6 million share offering By Investing.com - Investing.com Australia
Ventas announces 10.6 million share offering - Investing.com India
Ventas announces 10.6M share common stock offering - TipRanks
Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock - Business Wire
Is Wall Street Bullish Or Bearish On Ventas Stock? - Barchart
Assetmark Inc. Grows Holdings in Ventas, Inc. (NYSE:VTR) - MarketBeat
Brokerages Set Ventas, Inc. (NYSE:VTR) PT at $63.63 - MarketBeat
Here's Why Ventas Stock Is An Apt Portfolio Pick For Now - Barchart
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):